CompoAtlas

Carnitine Plus N-Acetylcysteine with Pterostilbene

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-Acétyl-L-cystéine

Source : N-Acétyl-L-cystéine

600 mgNot calculated
L-Carnitine

Source : L-tartrate de carnitine

2,000 mgNot calculated
4-[(3,5-diméthoxyphényl)éthényl]phénol

Source : Pterocarpus marsupium - duramen (tige)

100 mgNot calculated

Non-medicinal ingredients

Trehalose, Hydroxypropyle Cyclodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Cuillère à café1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of/Provides antioxidants. Helps improve physical performance when used in conjunction with a training regimen.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
LeralabInc
NPN or DIN-HM
80133265
Status
Active licence
Licence date
8 August 2024
Revision date
Not provided
Form
Poudre pour solution
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80133265

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-Carnitine
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line